NIAID's Dr. John Beigel has led the team implementing the Adaptive Covid-19 Treatment Trial (ACTT), the first large U.S. Covid-19 study launched after the first U.S. patients were identified. He and his colleagues continue testing several therapeutics toward finding better treatments.
In the summer of 2015, Dr. Mona Hanna-Attisha was drinking a glass of wine with a high school friend in Flint, Mich. Her pal, a drinking water expert, told her the tap water in Flint wasn’t treated properly and probably contained lead. “When I heard about lead, my life changed,” she recounted. “I became really consumed with what was happening with my Flint kids and how to best protect them.”
Velcro and tape are advancing molecular biology in microgravity, the unique environment where the effects of Earth’s gravity are minimal, said NASA astronaut and biologist Dr. Kate Rubins while aboard the International Space Station. “One of the hardest parts about doing laboratory science here is that you can have a bench, but nothing will stay on the bench,” she said.
On the Cover
Ebenezer Mienza, a respiratory therapist, was the first person at NIH to get vaccinated against Covid-19 on Dec. 22, 2020. Recently, NIH expanded employee vaccine eligibility, as the nation gradually begins to emerge from varying degrees of lockdown. Invitations to schedule a vaccine have now been sent to all Phase 4 staff, most of whom continue to work remotely. If you have an NIH staff ID badge and have not received a vaccine, you can schedule an appointment at NIH. As of Apr. 16, approximately 23,625 staffers have received at least a first dose of a Covid vaccine either at NIH or in their community.